Consecutive Fecal Calprotectin Measurements to Predict Relapse in Patients with Ulcerative Colitis Receiving Infliximab Maintenance Therapy - Concepedia

Concepedia

Publication | Open Access

Consecutive Fecal Calprotectin Measurements to Predict Relapse in Patients with Ulcerative Colitis Receiving Infliximab Maintenance Therapy

DOI Full Paper Access

202

Citations

18

References

2013

Year

Martine De Vos, Édouard Louis, Jørgen Jahnsen, Jo Vandervoort, Maja Noman, Olivier Dewit, Geert D’Haens, Denis Franchimont, Filip J. Baert, Roald Torp,

Inflammatory Bowel Diseases

Abstract

Fecal calprotectin can be used in daily practice to monitor patients with UC receiving infliximab maintenance therapy. Two consecutive measurements >300 mg/kg is more specific than a single measurement for predicting relapse.

References

	Year	Citations

Page 1